PLC is implicated in cancer due to its role in cell signaling pathways that regulate cell growth and survival. Dysregulation of PLC activity can lead to abnormal cell proliferation, one of the hallmarks of cancer. Overexpression or mutation of certain PLC isoforms has been observed in various cancers, including breast, prostate, and colorectal cancers.
